









Markets
/
Stocks
/
nasdaq-veev
/

Veeva Systems Inc

VEEV

276.270USD

-0.160-0.06%

Close 09/15, 16:00（ET）Quotes delayed by 15 min

45.27BMarket Cap

55.90P/E TTM



Veeva Systems Inc

276.270

-0.160-0.06%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-15

Key Insights

The company's fundamentals are relatively weak. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

10 / 207

Overall Ranking

92 / 4724

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 32 analysts

Buy

Current Rating

312.506

Target Price

+13.05%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. The Company offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and their strategic business functions from research and development (R&D) through commercialization. The Company’s three product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Vault Clinical advances clinical trial execution by providing a complete and connected technology ecosystem. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 27.45% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 46.43.

Fairly Valued

The company’s latest PE is 57.41, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 156.11M shares, decreasing 0.77% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 14.90M shares of this stock.

Financial Health

Currency: USD Updated：2025-09-15

The company's current financial score is 6.44, which is lower than the Healthcare Equipment & Supplies industry's average of 7.15. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 759.04M, representing a year-over-year increase of 16.71%, while its net profit experienced a year-over-year increase of 41.15%.

Score

Industry at a Glance

Previous score

6.44

Change

1.57



Financials

9.33

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.05

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.06

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

8.25

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.35

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-15

The company’s current valuation score is 4.80, which is higher than the Healthcare Equipment & Supplies industry's average of 2.15. Its current P/E ratio is 61.01, which is -2.56% below the recent high of 59.45 and 12.32% above the recent low of 53.50.

Score

Industry at a Glance

Previous score

4.37

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 10/207

No Data

Earnings Forecast

Currency: USD Updated：2025-09-15

The company’s current earnings forecast score is 7.56, which is lower than the Healthcare Equipment & Supplies industry's average of 7.66. The average price target for Veeva Systems Inc is 300.00, with a high of 335.00 and a low of 210.00.

Score

Industry at a Glance

Previous score

7.63

Change

Support & Resistance

No Data

Analyst Rating

Based on 32 analysts

Buy

Current Rating

312.506

Target Price

+13.05%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Veeva Systems Inc

VEEV

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Thermo Fisher Scientific Inc

TMO

Danaher Corp

DHR

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-15

The company’s current price momentum score is 9.24, which is higher than the Healthcare Equipment & Supplies industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 302.15 and the support level at 278.90, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.21

Change

-0.02

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

0.031

Neutral

RSI(14)

47.563

Neutral

STOCH(KDJ)(9,3,3)

65.893

Neutral

ATR(14)

8.126

High Vlolatility

CCI(14)

1.451

Neutral

Williams %R

59.542

Sell

TRIX(12,20)

-0.095

Sell

StochRSI(14)

22.804

Sell

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

277.890

Sell

MA10

275.615

Buy

MA20

279.330

Sell

MA50

281.150

Sell

MA100

270.150

Buy

MA200

248.363

Buy

Institutional Confidence

Currency: USD Updated：2025-09-15

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. The latest institutional shareholding proportion is 95.54%, representing a quarter-over-quarter increase of 0.06%. The largest institutional shareholder is The Vanguard, holding a total of 14.90M shares, representing 9.12% of shares outstanding, with 2.97% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

14.69M

+2.19%

Gassner (Peter P)

12.27M

BlackRock Institutional Trust Company, N.A.

6.94M

-0.02%

AllianceBernstein L.P.

5.50M

+10.72%

Fidelity Management & Research Company LLC

5.31M

+82.64%

T. Rowe Price Investment Management, Inc.

5.20M

+0.66%

Principal Global Investors (Equity)

3.15M

+6.35%

State Street Global Advisors (US)

3.46M

+1.49%

Geode Capital Management, L.L.C.

2.98M

+6.25%

MFS Investment Management

3.04M

-1.88%

Risk Assessment

Currency: USD Updated：2025-09-15

The company's beta value is 0.95. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.